Although AFP is the most commonly used biomarker in HCC, its reliability for screening and diagnosis remains suboptimal, as elevated APF level is also seen in gastrointestinal disease or benign liver disease [1]. The gene discussed is AFP; the disease is hepatocellular carcinoma.